A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance

作者：Ward Soracha E.; O'Sullivan Jamie M.^*; Drakeford Clive; Aguila Sonia; Jondle Christopher N.; Sharma Jyotika; Fallon Padraic G.; Brophy Teresa M.; Preston Roger J. S.; Smyth Paul; Sheils Orla; Chion Alain; O'Donnell James S.

来源：Blood, 2018, 131(8): 911-916.

DOI：10.1182/blood-2017-06-787853

Previous studies have shown that loss of terminal sialic acid causes enhanced von Willebrand factor (VWF) clearance through the Ashwell-Morrell receptor (AMR). In this study, we investigated (1) the specific importance of N-vs O-linked sialic acid in protecting against VWF clearance and (2) whether additional receptors contribute to the reduced half-life of hyposialylated VWF. alpha 2-3-linked sialic acid accounts for <20% of total sialic acid and is predominantly expressed on VWF O-glycans. Nevertheless, specific digestion with alpha 2-3 neuraminidase (alpha 2-3Neu-VWF) was sufficient to cause markedly enhanced VWF clearance. Interestingly, in vivo clearance experiments in dual VWF-/-/Asgr1(-/-) mice demonstrated enhanced clearance of alpha 2-3Neu-VWF even in the absence of the AMR. The macrophage galactose-type lectin (MGL) is a C-type lectin that binds to glycoproteins expressing terminal N-acetylgalactosamine or galactose residues. Importantly, the markedly enhanced clearance of hyposialylated VWF in VWF(-/-)Asgr1(-/-) mice was significantly attenuated in the presence of an anti-MGL inhibitory antibody. Furthermore, dose-dependent binding of human VWF to purified recombinant human MGL was confirmed using surface plasmon resonance. Additionally, plasma VWF: Ag levels were significantly elevated in MGL1(-/-) mice compared with controls. Collectively, these findings identify MGL as a novel macrophage receptor for VWF that significantly contributes to the clearance of both wild-type and hyposialylated VWF.

• 出版日期2018-2-22